Home Cart Sign in  
Chemical Structure| 2374856-75-2 Chemical Structure| 2374856-75-2

Structure of Evixapodlin
CAS No.: 2374856-75-2

Chemical Structure| 2374856-75-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Evixapodlin (GS-4224) is an inhibitor of the PD-1/PD-L1 protein-protein interaction, with an IC50 of 0.213 nM. Evixapodlin has anticancer and antiviral functions.

Synonyms: GS-4224; PD-1/PD-L1-IN 7

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Evixapodlin

CAS No. :2374856-75-2
Formula : C34H36Cl2N8O4
M.W : 691.61
SMILES Code : COC1=NC(C2=CC=CC(C3=C(Cl)C(C4=CN=C(CNC[C@@H]5CCC(N5)=O)C(OC)=N4)=CC=C3)=C2Cl)=CN=C1CNC[C@@H]6CCC(N6)=O
Synonyms :
GS-4224; PD-1/PD-L1-IN 7
MDL No. :MFCD33402309

Safety of Evixapodlin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Target
  • PD-1/PD-L1 interaction

    PD-1/PD-L1, IC50:0.213 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04049617 Advanced Solid Tumors PHASE1 TERMINATED 2021-03-30 California Care Associates for... More >> Research and Excellence Inc, Encinitas, California, 92024, United States|NEXT Oncology, San Antonio, Texas, 78229, United States|Northwest Medical Specialties, PLLC, Tacoma, Washington, 98405, United States|Auckland City Hospital, Auckland, 1023, New Zealand|Christchurch Clinical Studies Trust, LLC, Christchurch, 8011, New Zealand|Auckland Clinical Studies Ltd, Grafton, Auckland, 1010, New Zealand Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.45mL

0.29mL

0.14mL

7.23mL

1.45mL

0.72mL

14.46mL

2.89mL

1.45mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories